From: Secondary infections in critically ill patients with COVID-19
Study [ref] | Sample size | Setting | Incidence of secondary infections, % | Type and site of infection (%) | Microorganisms isolated (%) |
---|---|---|---|---|---|
Giacobbe et al. [27] | 78 | ICU | 40 | BSI (100) | Coag-neg staphylococci (24) E. faecalis (18) S. aureus (13) |
He et al. [46] | 918 | Hospital | 7 | Pneumonia (32) BSI (25) UTI (22) | Coag-staphylococci (28) A. baumannii (21) P. aeruginosa (14) |
Sharifipour et al. [26] | 19 | ICU | 100a | VAP (100) | A. baumannii (90) S. aureus (10) |
Fu et al. [47] | 36 | ICU | 14 | VAP (100) | S. mantophilia (40) |
Li et al. [48] | 1495 | Hospital | 7 | Pneumonia (86) BSI (34) UTI (8) | A. baumannii (36) K. pneumoniae (31) S. mantophilia (6) |
Rouzé et al. [24] | 568 | ICU | 51 | VAP (71) VAT (29) | P. aeruginosa (22) Enterobacter spp. (18) S. aureus (12) |
Buetti et al. [28] | 321 | ICU | 15 | BSI | Coag-staphylococci (36) Enterobacterales (13) P. aeruginosa (13) |
Dudoignon et al. [49] | 54 | ICU | 37 | VAP (75) | P. aeruginosa (33) Enterobacteriaceae (33) S. aureus (20) |
Ripa et al. [50] | 731 | Hospital | 9 | BSI (85) LRTI (32) | Coag-staphylococci 70% of BSI A. baumannii 30% of LRTI |